menu
    • menu
    PHARMACOMPASS
    PHARMACOMPASS

    Grow Your Pharma Business Digitally
    X
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Intra-Cellular Therapies Reports Q4 & Full-Year 2024 Results

    GLOBENEWSWIRE

    J&J doubles down on neurological drugs with $14.6 billion deal

    REUTERS

    J&J explores bid for Intra-Cellular Therapies, reports

    REUTERS

    Intra-Cellular Settles Caplyta Patent Litigation with Sandoz

    GLOBENEWSWIRE

    Intra-Cellular Therapies to Present at 43rd J.P. Morgan Conference

    GLOBENEWSWIRE

    Intra-Cellular Therapies Presents Ph 3 Data at ACNP Annual Meeting

    GLOBENEWSWIRE

    Intra-Cellular Submit sNDA for Caplyta in Major Depressive Disorder

    GLOBENEWSWIRE

    Intra-Cellular To Participate In 3 Upcoming Investor Conferences

    GLOBENEWSWIRE

    Intra-Cellular Therapies Present at Psych Congress & NEI Congress

    GLOBENEWSWIRE

    Intra-Cellular`s unstoppable Caplyta nails another trial

    FIERCE PHARMA

    Intra-Cellular Therapies Reports Q3 Results, Raises Sales Guidance

    GLOBENEWSWIRE

    Intra-Cellular To Host Q3 2024 Financial Results Webcast

    GLOBENEWSWIRE

    Intra-Cellular Reports ECNP Congress 2024 Presentations

    GLOBENEWSWIRE

    Intra-Cellular Therapies to Present at Three Upcoming Investor Conferences

    GLOBENEWSWIRE

    Intra-Cellular To Present At Canaccord Genuity Growth Conference

    GLOBENEWSWIRE

    Intra-Cellular Reports Q2 2024 Results, Raises CAPLYTA Sales Guidance

    GLOBENEWSWIRE

    Intra-Cellular Therapies Appoints Sanjeev Narula As CFO

    GLOBENEWSWIRE

    Intra-Cellular Therapies To Host Q2 2024 Results Call And Webcast

    GLOBENEWSWIRE

    Intra-Cellular closing in on major depression nod for Caplyta

    FIERCE PHARMA

    Intra-Cellular Announces Positive Phase 3 Results For Lumateperone In Depression

    GLOBENEWSWIRE

    Intra-Cellular To Present At Goldman Sachs Healthcare Conference

    GLOBENEWSWIRE

    Intra-Cellular At Jefferies Healthcare Conference

    GLOBENEWSWIRE

    Intra-Cellular Psychopharmacology Data: Annual Meeting Presentations Highlighted

    GLOBENEWSWIRE

    Intra-Cellular Therapies to Participate in Two Upcoming Investor Conferences

    GLOBENEWSWIRE

    Intra-Cellular Therapies Reports First Quarter 2024 Financial Results

    GLOBENEWSWIRE

    Intra-Cellular Q1 2024 Results Call And Webcast

    GLOBENEWSWIRE

    Intra-Cellular Closes $575M Public Offering

    GLOBENEWSWIRE

    Intra-Cellular Therapies Prices Public Offering of Common Stock

    GLOBENEWSWIRE

    Intra-Cellular Announces Positive Phase 3 Results for Lumateperone in MDD

    GLOBENEWSWIRE

    Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock

    GLOBENEWSWIRE

    Intra-Cellular Therapies Promotes Dr. Michael Halstead to President

    CONTRACT PHARMA

    Intra-Cellular Therapies Announces Executive Appointments and Leadership Changes

    GLOBENEWSWIRE

    Intra-Cellular Therapies to Participate in Three Upcoming Investor Conferences

    GLOBENEWSWIRE

    Intra-Cellular to Present at the 44th Annual TD Cowen Health Care Conference

    GLOBENEWSWIRE

    Intra-Cellular Reports Fourth Quarter And Full-Year 2023 Financial Results

    GLOBENEWSWIRE

    Intra-Cellular to Host Fourth Quarter and Full Year 2023 Financial Results

    GLOBENEWSWIRE

    Intra-Cellular to Present at the 42nd Annual J.P. Morgan Healthcare Conference

    GLOBENEWSWIRE

    Intra-Cellular Therapies Highlights Data Presentations at Annual Meeting

    GLOBENEWSWIRE

    Intra-Cellular to Present at the 6th Annual Evercore ISI HealthCONx Conference

    GLOBENEWSWIRE

    Intra-Cellular Therapies Reports Third Quarter 2023 Financial Results

    GLOBENEWSWIRE

    Intra-Cellular Therapies to Participate in Two Upcoming Investor Conferences

    GLOBENEWSWIRE

    Intra-Cellular to Host Third Quarter 2023 Financial Results Conference

    GLOBENEWSWIRE

    Intra-Cellular to Present at the 2023 Cantor Fitzgerald Global Conference

    GLOBENEWSWIRE

    Intra-Cellular Announces Positive Results from Study 403 in Mixed Features

    PRESS RELEASE

    Intra-Cellular Therapies Announces Presentations at Psych Congress 2023

    GLOBENEWSWIRE

    Intra-Cellular to Present at the Morgan Stanley 21st Annual Global Conference

    GLOBENEWSWIRE

    Intra-Cellular re-ups winning ad as bipolar drug builds momentum

    FIERCE PHARMA

    Intra-Cellular Therapies to Present at Canaccord Genuity 43rd Annual Conference

    GLOBENEWSWIRE

    Intra-Cellular Therapies Reports Second Quarter 2023 Financial Results

    GLOBENEWSWIRE

    Intra-Cellular Therapies to Host Q2 2023 Financial Results Conference

    GLOBENEWSWIRE

    Intra-Cellular shareholders have earned a 25% CAGR over the last five years

    SIMPLYWALL

    Intra-Cellular to Present at the Goldman Sachs 44th Annual Global Conference

    GLOBENEWSWIRE

    Intra-Cellular Therapies Announces CAPLYTA Data Presentations

    GLOBENEWSWIRE

    Intra-Cellular Therapies Reports 1Q 2023 FYR and Provides Corporate Update

    GLOBENEWSWIRE

    Intra-Cellular Therapies to Present at Two Upcoming Investor Conferences

    GLOBENEWSWIRE

    Intra-Cellular Therapies to Host 1Q 2023 FYR Conference Call and Webcast

    GLOBENEWSWIRE

    Morgan Stanley Initiates Coverage of ITCI with Overweight Recommendation

    NASDAQ

    Intra-Cellular to Present at 22nd Annual Needham Virtual Healthcare Conference

    GLOBENEWSWIRE

    Intra-Cellular Therapies gets a boost on PhIII depression drug data

    ENDPTS

    Intra-Cellular Announces Positive Results from Study 403 Evaluating Lumateperone

    GLOBENEWSWIRE

    Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.